pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
6,918
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
Stem Cell Therapy for Coronavirus Disease 2019 (COVID-19)
Coronavirus Disease 2019 (COVID-19) Associated Acute Resp…
Stemedica Cell Technologies Inc
Preclinical
Stem Cell Therapy for Ophthalmology
no indication
University of California Los Angeles
Phase 2
Stemchymal
Spinocerebellar Ataxia (SCA)
Steminent Biotherapeutics Inc
← prev
page 138 of 231
next →
131
Pain
89
Neurology
1
Phase 2
Stenoparib
Epithelial Ovarian Cancer
$ALLR
Allarity Therapeutics, Inc.
Phase 2
Streptococcus vaccine
Streptococcal Infections
Minervax ApS
Preclinical
StroMel
StroMel
Osteoarthritis
Akan Biosciences LLC
Marketed
Strontium chloride Sr 89
Strontium Chloride SR-89 (strontium chloride)
Ostealgia (Bone Pain)
Q BioMed Inc
Marketed
Sular
Nisoldipine Prasco (nisoldipine)
Angina (Angina Pectoris)
Prasco LLC
Preclinical
SuppoCan
Inflammatory Bowel Disease
$IXHL
Incannex Healthcare Inc.
Phase 2
SurVaxM
Glioblastoma Multiforme (GBM)
MimiVax LLC
Marketed
Syfovre
Syfovre (pegcetacoplan)
Geographic Atrophy
$APLS
Apellis Pharmaceuticals, Inc.
Marketed
Sylatron
Sylatron (peginterferon alfa-2b)
Melanoma
$MRK
Merck & Co., Inc.
Phase 1
SynKIR-110
Bile Duct Cancer (Cholangiocarcinoma)
Verismo Therapeutics Inc
Phase 1
SynKIR-310
Diffuse Large B-Cell Lymphoma
Verismo Therapeutics Inc
Preclinical
Synthetic Transporter
Menkes Disease (Kinky Hair Disease)
University of Lorraine
Phase 1
T-1101
Neuroendocrine Tumors
Taivex Therapeutics Inc
Phase 2
T-3D959
Alzheimer's Disease
T3D Therapeutics Inc
Preclinical
T-Cell Therapy
Solid Tumor
Eureka Therapeutics Inc
Preclinical
TAGX-0004
Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease)
TagCyx Biotechnologies
Phase 2
TAK-101
Celiac Disease
$TAK
TAKEDA PHARMACEUTICAL CO LTD
Phase 2
TAK-360
Type 2 Narcolepsy (Narcolepsy without Cataplexy)
$TAK
TAKEDA PHARMACEUTICAL CO LTD
Phase 3
TAK-881
Primary Immune Deficiency (PID)
$TAK
TAKEDA PHARMACEUTICAL CO LTD
Phase 2
TARA-002
Unspecified Rare Disease
$TARA
Protara Therapeutics, Inc.
Phase 2
TAS-0728
Solid Tumor
Taiho Pharmaceutical Co Ltd
Phase 1
TAS-2940
Solid Tumor
Taiho Oncology Inc
Phase 1
TAVO-412
Gastric Cancer
Tavotek Biotherapeutics
Phase 2
TB-006
Alzheimer's Disease
TrueBinding Inc
Preclinical
TB-500
Inflammation
PharmaTher Holdings Ltd
Preclinical
TB-511
Hepatocellular Carcinoma
Twinpigbiolab Co Ltd
Phase 2
TBA-7371
Pulmonary Tuberculosis
$AZN
ASTRAZENECA PLC
